Yüklüyor......
Landscape of clinically actionable mutations in breast cancer ‘A cohort study’
Breast cancer (BC) is a heterogeneous disease. Numerous chemotherapeutic agents are available for early stage or advanced/metastatic breast cancer to provide maximum benefit with minimum side effects. However, the clinical outcome of patients with the same clinical and pathological characteristics a...
Kaydedildi:
| Yayımlandı: | Transl Oncol |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Neoplasia Press
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7581976/ https://ncbi.nlm.nih.gov/pubmed/33099186 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2020.100877 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|